Molecular Imaging: Page 99

Hoag launches PET trials for prostate cancer, myeloma

By AuntMinnie.com staff writers

Hoag Family Cancer Institute is launching two new clinical trials for PET radiotracers: a myeloma imaging trial in the U.S. and a prostate cancer molecular therapy trial in Orange County, CA.

April 20, 2021

Shine merges with nuclear technology firm Phoenix

By AuntMinnie.com staff writers

Nuclear technology company Phoenix has become a wholly owned subsidiary of medical isotope firm Shine Medical Technologies, the companies announced.

April 20, 2021

PET tracers reveal long-term consequences of brain injuries

By Will Morton

PET/MRI scans with novel radiotracers indicate that young athletes may suffer from long-term neurodegeneration after experiencing multiple sports-related brain injuries, according to a recent study by a group of Swedish researchers.

April 20, 2021

Canon Medical, RaySearch expand partnership

By AuntMinnie.com staff writers

Canon Medical Systems USA said it is expanding its partnership with RaySearch Laboratories to distribute Canon CT and PET/CT scanners in the U.S.

April 14, 2021

PET shows slow cognitive recovery in chronic COVID-19 patients

By Will Morton

FDG-PET scans and cognitive function tests showed that patients with chronic COVID-19 who suffer from neurological impairment had not yet returned to normal after six months in a recent study by German researchers.

April 14, 2021

Reps. ask CMS to change policy on radiopharmaceuticals

By AuntMinnie.com staff writers

Two members of the U.S. House of Representatives have asked the U.S. Centers for Medicare and Medicaid Services (CMS) to change what they said was a fundamentally flawed policy of reimbursing diagnostic radiopharmaceuticals as ancillary supplies for procedures.

April 13, 2021

MTTI wins patent for PET necrosis imaging agent

By AuntMinnie.com staff writers

Biopharmaceutical company Molecular Targeting Technologies (MTTI) has received a patent from the U.S. Patent and Trademark Office for its F-18 fluoroglucaric acid PET necrosis imaging agent.

April 12, 2021

Eckert & Ziegler secures technetium licenses for Brazil

By AuntMinnie.com staff writers

Isotope technology firm Eckert & Ziegler has secured a license to market technetium generators in Brazil from that country's regulatory body, ANVISA.

April 11, 2021

iTheranostics, Novartis ink FAP-targeted drug development agreement

By AuntMinnie.com staff writers

Sofie subsidiary iTheranostics has inked an agreement with Novartis to collaborate on the development of therapeutic fibroblast activation protein (FAP) drugs.

April 8, 2021

Lantheus announces new R&D hires

By AuntMinnie.com staff writers

Lantheus Medical Imaging parent company Lantheus Holdings has expanded its research and development team with two new hires.

April 6, 2021

FDG-PET/CT effective for staging in new breast cancer

By Will Morton

FDG-PET/CT scans are a valuable tool for staging women newly diagnosed with breast cancer, according to a study published online April 3 in Surgical Oncology. Researchers from Israel found a significant correlation between FDG uptake and breast tumor size and grade.

April 6, 2021

Radium-223 treatment in men increases risk of bone fracture

By Will Morton

Bone health agents should be mandatory to help prevent fractures in men who receive radionuclide therapy with radium-223 for prostate cancer, according to a study published online April 4 in Clinical Genitourinary Cancer.

April 5, 2021

Previous Page

Page 99 of 614

Next Page